To increase tumor incidence and better assess the role of systemic expression of TP53 in responses to initiation of uterine LMS tumorigenesis, LMP2-deficient mice were bred with TP53-deficient mice to create Lmp2−/−Tp53−/− double knockout mice. Here, PSMB9 is linked to neoplasm.